News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
98 Results
Type
Article (3)
Press Release (95)
Section
Business (23)
Deals (1)
Drug Development (2)
FDA (2)
News (27)
Tag
Alliances (7)
Approvals (2)
Clinical research (2)
Diagnostics (1)
Earnings (2)
Events (17)
FDA (2)
Healthcare (14)
IPO (1)
Medical device (6)
Medtech (6)
NextGen: Class of 2025 (1)
Patient recruitment (1)
People (7)
Phase I (1)
Phase II (1)
Phase III (1)
Real estate (5)
Startups (2)
United States (3)
Date
Last 365 days (8)
2025 (1)
2024 (7)
2023 (7)
2022 (4)
2021 (9)
2020 (9)
2019 (21)
2018 (8)
2017 (5)
2016 (2)
2014 (3)
2013 (2)
2012 (4)
2011 (2)
2010 (2)
Location
Asia (2)
Colorado (1)
Europe (3)
New Jersey (1)
North Carolina (1)
98 Results for "sentara".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Remission Medical Partners with Sentara Health to Expand Access to Rheumatology Care
Remission Medical announced a partnership with Sentara Health to increase access to Rheumatology care for adult patients.
March 20, 2024
·
2 min read
Press Releases
SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial
December 4, 2024
·
8 min read
Business
Sentara Healthcare Selects Mach7 for PACS Replacement
Mach7 Technologies Inc., a company specializing in innovative data management solutions for healthcare providers, announced it has been contracted by Sentara Healthcare for its Picture Archiving and Communication System modernization project.
April 16, 2019
·
3 min read
Business
Sentara Healthcare To Build A Cancer Center
The Sentara Cancer Center will provide a centralized hub of services for compassionate, personalized, and convenient cancer care
March 8, 2018
·
4 min read
Biotech Bay
Cigna and Sentara Healthcare Expand Blockchain-Based Ecosystem for Healthcare Industry - Along with Aetna, Anthem, Health Care Service Corporation, PNC Bank and IBM
IBM announced that Cigna and Sentara Healthcare have joined a new health utility network using blockchain.
February 13, 2019
·
8 min read
BioCapital
Sentara RMH Medical Center Partners with Omnicell to Enhance Efficiency, Safety in Central Pharmacy Operations
Leveraging Automation Frees Staff to Focus on Clinical Care [10-May-2018] Sentara RMH Medical Center Partners with Omnicell to Enhance Efficiency, Safety in Central Pharmacy Operations Leveraging Automation Frees Staff to Focus on Clinical Care MOUNTAIN VIEW,
May 10, 2018
·
4 min read
BioCapital
Patients with Complex Chronic Illnesses Can Now Receive More Affordable Medications and New Pharmacy Services With No Added Costs
Partnership between Shields Health Solutions and Sentara Healthcare brings patients more support services, increased number of specialty drugs and expanded insurance coverage
February 24, 2021
·
4 min read
Pharm Country
Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors
Lucid Diagnostics Inc. a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc., announced the Company has closed a Series B-1 Preferred Stock offering led by one of the Company’s long-time institutional investors, with gross proceeds of $11.6 million, bringing the total Series B / B-1 gross proceeds to $29.8 million.
May 7, 2024
·
6 min read
Genetown
Two Case Studies Presented at IHI National Forum Demonstrate Use of Glytec’s Technology and Services Leads to Improved Glycemic Outcomes
In partnership with clinical leaders from AdventHealth Waterman and Sentara Virginia Beach General Hospital, Glytec presented two storyboards at the IHI National Forum revealing significant quality and safety improvements for hospitalized patients receiving insulin therapy.
December 11, 2019
·
3 min read
BioCapital
KeViRx, Inc. Awarded $1.99 Million
KeViRx, Inc., an innovative, early-stage pharmaceutical company, announced the receipt of $1.99 million in grant funding from the U.S. Department of Defense’s Peer Reviewed Medical Research Program.
June 11, 2024
·
3 min read
1 of 10
Next